RBC Positive on Sarepta Therapeutics (SRPT) Into Tomorrow's R&D Day
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $18.79 -2.24%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
RBC Capital analsyt Brian Abrahams notes the agenda for Sarepta Therapeutics (NASDAQ: SRPT) R&D Day tomorrow was just made available here.
The analsyt continues to like the prospects for microdystrophin data, which will be presented at 9:20am ET.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- Cummins (CMI) PT Lowered to $675 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, FDA, Trader TalkRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
